双重序贯除颤治疗院外心脏骤停:伦敦经验
本研究为回顾性观察分析,纳入伦敦救护服务2015年7月1日至2016年12月31日期间接受双重序贯除颤(DSD)的院外心脏骤停患者45例,并设持续室颤接受超过6次连续标准除颤(非DSD)的对照组。DSD组约三分之一获得院前自主循环恢复(ROSC),7%存活至出院;标准除颤组的ROSC和存活率相似。作者结论认为观察性研究未发现DSD对难治性室颤有明确益处,但3例在单次除颤失败后接受DSD者室颤终止,亟需前瞻性随机临床试验验证。
要点
- DSD组45例院外心脏骤停患者中,约三分之一获得院前ROSC,7%存活至出院。
- 接受标准除颤(超过6次连续标准除颤)的对照组,ROSC和存活率与DSD组相似。
- 3例在单次除颤失败后接受DSD的患者室颤终止。
- 作者结论:观察性研究未发现EMS使用DSD治疗难治性室颤有明确益处。
- 作者认为亟需前瞻性随机临床试验研究DSD在院前环境中的潜在价值。
适用人群与场景
- 院外心脏骤停(OHCA)且复苏期间处于难治性室颤(RVF)的患者。
- 伦敦救护服务2015年7月1日至2016年12月31日期间接受DSD的患者45例。
- 对照组为持续室颤接受超过6次连续标准除颤(非DSD)的患者。
处置流程与药物剂量
- DSD操作为快速连续给予两次电击。
- 伦敦救护服务使用当地DSD方案尝试终止难治性室颤。
研究设计与关键结果
- 研究类型:回顾性观察分析;样本量:DSD组45例;研究时段:2015年7月1日至2016年12月31日(18个月)。
- DSD组约三分之一获得院前ROSC,7%存活至出院。
- 标准除颤(超过6次连续标准除颤)组的ROSC和存活率与DSD组相似。
- 3例在单次除颤失败后接受DSD的患者室颤终止。
证据类型、等级与局限
- 证据类型:回顾性观察分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论:观察性研究未发现EMS使用DSD治疗难治性室颤有明确益处。
- 作者认为亟需前瞻性随机临床试验研究DSD在院前环境中的潜在价值。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Despite advances in treatment for out-of-hospital cardiac arrest (OHCA), a subgroup of patients remain in refractory ventricular fibrillation (RVF) during resuscitation. Recent evidence suggests that double sequential defibrillation (DSD), where two shocks are delivered to the patient in quick succession, may provide an effective therapy for RVF. This study describes the characteristics and survival outcomes of OHCA patients treated by ambulance clinicians using a local DSD protocol in an attempt to resolve RVF.
METHODS: This is a retrospective, observational analysis of patients who received DSD by the London Ambulance Service from 1st July 2015 to 31st December 2016. A comparator group of patients who received more than six consecutive standard shocks (not DSD) for persistent VF was also identified. Outcomes included pre-hospital return of spontaneous circulation (ROSC), ROSC sustained to hospital, and survival to hospital discharge. DSD patients who survived to hospital discharge are reported in further detail.
RESULTS: During the 18-month study period, 45 patients were treated with DSD: a third obtained a pre-hospital ROSC and 7% survived to hospital discharge. We observed similar ROSC and survival rates amongst those who received standard defibrillation only.
CONCLUSION: Our observational study did not find any clear benefit of DSD use by EMS in the treatment of RVF. However, we find that 3 patients, who were treated with DSD following unsuccessful single shocks, had their VF terminated. Prospective randomised clinical trials are urgently needed to investigate the potential value of DSD in the pre-hospital setting.
参考来源
- Emmerson AC, Whitbread M, Fothergill RT, et al. Double sequential defibrillation therapy for out-of-hospital cardiac arrests: The London experience. Resuscitation. 2017. PMID: 28624593. doi:10.1016/j.resuscitation.2017.06.011
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。